1. Home
  2. OPK

OPK

OPKO Health Inc.

as 04-18-2025 1:41pm EST

$
-
.
-
-
-
$
-
.
-
-
-
.
-
-
%

Stocks

Health Care

Biotechnology: Pharmaceutical Preparations

Nasdaq

Founded: 2007 Country:
United States
United States
Employees: N/A City: MIAMI
Market Cap: N/A IPO Year: 1995
Target Price: $2.75 AVG Volume (30 days): 3.8M
Analyst Decision: Strong Buy Number of Analysts: 3
Dividend Yield:
N/A
Dividend Payout Frequency: N/A
EPS: -0.08 EPS Growth: N/A
52 Week Low/High: $1.15 - $2.04 Next Earning Date: 04-30-2025
Revenue: $713,142,000 Revenue Growth: -17.41%
Revenue Growth (this year): -6.17% Revenue Growth (next year): 8.11%

OPK Daily Stock ML Predictions

Stock Insider Trading Activity of OPKO Health Inc. (OPK)

Name Ticker Relationship Date Transaction AVG Cost Per Share Shares Total Value Securities Owned After Transaction(s) SEC Form 4
FROST PHILLIP MD ET AL OPK CEO & Chairman Apr 1 '25 Buy $1.65 100,000 $164,850.00 213,751,448
FROST PHILLIP MD ET AL OPK CEO & Chairman Mar 28 '25 Buy $1.70 150,000 $254,385.00 213,751,448
FROST PHILLIP MD ET AL OPK CEO & Chairman Mar 17 '25 Buy $1.74 200,000 $347,820.00 213,751,448
FROST PHILLIP MD ET AL OPK CEO & Chairman Feb 28 '25 Buy $1.71 67,434 $115,312.14 213,751,448
FROST PHILLIP MD ET AL OPK CEO & Chairman Jan 28 '25 Buy $1.47 47,537 $70,060.03 213,751,448

Share on Social Networks: